Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.

Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo. Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3214-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.